AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,003,000 | +46.6% | 436,183 | +202.7% | 0.01% | +40.0% |
| Q4 2021 | $684,000 | +65.6% | 144,093 | +143.0% | 0.01% | +66.7% |
| Q2 2021 | $413,000 | -72.5% | 59,294 | -68.7% | 0.00% | -75.0% |
| Q1 2021 | $1,500,000 | +63.9% | 189,433 | +62.9% | 0.01% | +50.0% |
| Q4 2020 | $915,000 | -46.6% | 116,267 | -51.9% | 0.01% | -55.6% |
| Q3 2020 | $1,712,000 | +820.4% | 241,476 | +505.2% | 0.02% | +800.0% |
| Q1 2020 | $186,000 | -43.3% | 39,903 | -16.6% | 0.00% | -60.0% |
| Q2 2019 | $328,000 | +131.0% | 47,853 | +257.7% | 0.01% | +150.0% |
| Q2 2018 | $142,000 | +67.1% | 13,379 | -14.7% | 0.00% | +100.0% |
| Q4 2017 | $85,000 | – | 15,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,291,151 | $8,844,000 | 3.78% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 335,279 | $2,297,000 | 2.84% |
| Abingworth LLP | 240,500 | $1,638,000 | 0.63% |
| Nantahala Capital Management | 2,852,260 | $19,538,000 | 0.60% |
| RITHOLTZ WEALTH MANAGEMENT | 290,534 | $1,990,000 | 0.34% |
| Orbimed Advisors | 2,165,524 | $14,834,000 | 0.23% |
| Rock Springs Capital Management LP | 800,000 | $5,480,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 187,206 | $1,282,000 | 0.18% |
| Leap Investments LP | 16,600 | $114,000 | 0.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 500,046 | $3,425,000 | 0.12% |